• 검색 결과가 없습니다.

■ S-383 ■ Factors associated with Overactive bladder symptom score in patients with type 2 diabetes mellitus

N/A
N/A
Protected

Academic year: 2022

Share "■ S-383 ■ Factors associated with Overactive bladder symptom score in patients with type 2 diabetes mellitus"

Copied!
1
0
0

로드 중.... (전체 텍스트 보기)

전체 글

(1)

2021년 제72차 대한내과학회 추계학술대회 423

■S-383 ■ Factors associated with Overactive bladder symptom score in patients

with type 2 diabetes mellitus

부산대학교병원 내분비내과1, 부산성모병원 내분비내과2

임명수

1

, 김상수

1

, 이창원

2

, 이욱

1

, 양소리

1

, 김인주

1

Background/Aims: Overactive bladder (OAB) is a common urologic condition, known to be more prevalent in patients with type 2 diabetes mellitus than in those without diabetes. Previous studies investigated the risk factors associated with diabetes mellitus that influence OAB. However, few researches have been conducted in Korean type 2 diabetes mellitus. Thus, the aim of this study is to analyze overactive bladder symptom score (OABSS) in Korean patients with type 2 diabetes mellitus and to find factors associated with OABSS.

Methods: This cross-sectional case-control study enrolled T2DM patients (n=260) including 129 male and 131 female patients. All participants underwent physical examinations and laboratory tests. Overactive Bladder Symptom Score (OABSS) was assessed by questionnaire, which consists of a total of 4 questions regarding daytime frequency, nocturia, urgency, and urinary incontinence. The overall score is the sum of the 4 scores, and the severity of OAB is divided into “mild”, total score of 1 to 5, and “moderate to severe”, total score of 6 to 15. We also checked chronic complication status, brachial-ankle pulse wave velocity (baPWV, VP-1000, Colin, Japan) and diabetic cardiac autonomic neuropathy (DiCAN, Medicore, Seoul, Korea). Data were expressed as mean ± standard error.

Independent t-tests or chi-square tests were used to make comparisons between groups and Pearson’s correlation coefficient was used for correlation analysis.

Results: Comparison of baseline characteristics between male and female T2DM patients is shown in Table 1. Female T2DM patient group had higher prevalence (19% vs. 8%, p=0.008) of “moderate to severe” OABSS than male T2DM patient group (Figure). OABSS had statistically significant correlation with age, height, PWVmax, microalbuminuria (Table 2). As we divide T2DM patients into two groups by gender, however, the correlation of OABSS with age, PWVmax and microalbuminuria was significant only in male T2DM patients (Table 3). In addition, duration of T2DM was also correlated with OABSS in male T2DM patients.

Conclusions: OABSS had significant correlation with duration of T2DM, PWVmax and microalbuminuria in men with T2DM, but not in women with T2DM.

참조

관련 문서

Background: To investigate the association between diabetic retinopathy (DR) and myocardial dysfunction in patients with type 2 diabetes and dilated cardiomyopathy (dCMP)..

Incidence and risk factors associated with abnormal postpartum glucose tolerance in women with gestational diabetes. Ethnic differences in perinatal outcome

The aim of this study was to determine the prevalence of diabetes mellitus in patients with sickle cell disease in a country with a high prevalence of both disorders. Methods:

By contrast, treatment with oleanolic aicd induced nuclear Nrf2 abundance and increased HO-1, without increases of total Nrf2 and Keap1, indicating that oleanolic aicd

Glycemic control might have important impact on lipid profi le in type 2 diabetes mellitus patients. Methods: This cross sectional study was carried out in endocrine polyclinic

The Influence of Diabetes Mellitus on Diastolic Function in Patients with Non-Ischemic Left Ventricular Systolic Dysfunction.. Division of Cardiology, Department of

adverse changes in the financial condition of joint venture partner(s) or major tenants; risks associated with the acquisition, development, expansion, leasing and management

- Perform an annual test to assess urine albumin excretion in type 1 diabetic patients with diabetes duration of ≥ 5 years and in all type 2 diabetic patients starting at